@article{d5a94e4906a4434fabba25bd3d1b7ae3,
title = "Immune modulators as therapeutic agents for cutaneous T-Cell lymphoma",
abstract = "Cutaneous T-cell lymphoma at all stages appears to be responsive to immune modulatory therapeutic approaches. We describe here the mechanistic rationale for the use of interferons, interleukin-12, retinoids, Toll-like receptor agonists, photopheresis and combinations of immune preserving, immune stimulatory therapies for CTCL.",
keywords = "Bexarotene, CTCL, Drug approval, Interferon, Vorinostat",
author = "Rook, {Alain H.} and Bernice Benoit and Kim, {Ellen J.} and Vittorio, {Carmela C.} and Aleksandra Anshelevich and Raphael, {Brian A.} and Introcaso, {Camille E.} and Gardner, {Jennifer M.} and Evans, {Katherine G.} and Kelly Morrissey and Sara Samimi and Musiek, {Amy C.} and Showe, {Louise C.} and Wasik, {Mariusz A.} and Maria Wysocka",
year = "2010",
month = sep,
doi = "10.3816/CLML.2010.s.017",
language = "English",
volume = "10",
pages = "S93--S95",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Elsevier Inc.",
number = "SUPPL. 2",
}
